Is Levothyroxine safe during pregnancy?

Pregnancy category and evidence

Levothyroxine (synthetic T4) is not only safe in pregnancy — it is essential. Maternal thyroid hormone is required for fetal brain development, particularly in the first trimester before the fetal thyroid gland is functional. Under the former FDA categories it is Category A. Every major obstetric and endocrine society — ATA, ACOG, Endocrine Society — recommends uninterrupted levothyroxine treatment in pregnant patients with hypothyroidism.

By trimester

• First trimester (weeks 1–12): dose usually needs to increase by 25–30% at pregnancy diagnosis. This is the highest-stakes period for fetal brain development — undertreatment is the concern, not the drug itself. Target TSH <2.5 mIU/L.
• Second trimester (13–27): continue adjusted dose; check TSH every 4–6 weeks. Target TSH 0.2–3.0 mIU/L (pregnancy-specific range).
• Third trimester (28–40): dose may plateau. Continue monitoring.
• Postpartum: drop back to pre-pregnancy dose; recheck TSH in 6 weeks.

Safer alternatives

None needed. Synthetic T4 (levothyroxine) is the standard of care. Desiccated thyroid extract (Armour Thyroid, NP Thyroid) contains T3 and is not recommended in pregnancy due to unpredictable T3 delivery across the placenta and risk of suppressing fetal brain development.

When it's acceptable and when to be cautious

• Always continue levothyroxine during pregnancy in hypothyroid patients. Stopping is harmful to both mother and baby.
• Timing of doses and prenatal vitamins: iron, calcium, and prenatal multivitamins impair levothyroxine absorption. Take levothyroxine on an empty stomach, 4 hours apart from any supplements.
• Over-replacement causes problems too — targets are tighter in pregnancy (TSH <2.5 in first trimester). Check TSH monthly until stable, then every trimester.